Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Kalmar

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Oral and Maxillofacial Surgery Clinics of North America|December 20, 2007
Advances in the detection and diagnosis of oral precancerous and cancerous lesionsJohn R Kalmar
Oral Diseases|April 27, 2012
Commentary on proposed new classification system for BRONJJohn R Kalmar
International Journal of Oral and Maxillofacial Surgery|October 31, 2012
A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289]John R Kalmar
Journal of the California Dental Association|September 14, 2007
Diagnosis and management of oral lichen planusJohn R Kalmar
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 26, 2021
Why Doesn't Medicare Treat All Diagnostic Tests Equally?Mark W Lingen, John R Kalmar
The Alpha Omegan|March 14, 2008
Osteonecrosis of the jaws and bisphosphonatesSook-Bin Woo, John R Kalmar
Seminars in Diagnostic Pathology|April 28, 2023
Pearls and pitfalls in the diagnosis of small oral biopsiesKristin K McNamara, John R Kalmar
Head and Neck Pathology|May 25, 2012
Intraoral phaeohyphomycosisYeshwant B Rawal, John R Kalmar
Journal of Periodontology|March 15, 2018
FcγRIIa (CD32): A Potential Marker Defining Susceptibility to Localized Juvenile PeriodontitisMark E Wilson, John R Kalmar
Head and Neck Pathology|January 30, 2019
Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red EntitiesKristin K McNamara, John R Kalmar
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Oral and Maxillofacial Surgery Clinics of North America|December 20, 2007
Advances in the detection and diagnosis of oral precancerous and cancerous lesionsJohn R Kalmar
Oral Diseases|April 27, 2012
Commentary on proposed new classification system for BRONJJohn R Kalmar
International Journal of Oral and Maxillofacial Surgery|October 31, 2012
A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289]John R Kalmar
Journal of the California Dental Association|September 14, 2007
Diagnosis and management of oral lichen planusJohn R Kalmar
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 26, 2021
Why Doesn't Medicare Treat All Diagnostic Tests Equally?Mark W Lingen, John R Kalmar
The Alpha Omegan|March 14, 2008
Osteonecrosis of the jaws and bisphosphonatesSook-Bin Woo, John R Kalmar
Seminars in Diagnostic Pathology|April 28, 2023
Pearls and pitfalls in the diagnosis of small oral biopsiesKristin K McNamara, John R Kalmar
Head and Neck Pathology|May 25, 2012
Intraoral phaeohyphomycosisYeshwant B Rawal, John R Kalmar
Journal of Periodontology|March 15, 2018
FcγRIIa (CD32): A Potential Marker Defining Susceptibility to Localized Juvenile PeriodontitisMark E Wilson, John R Kalmar
Head and Neck Pathology|January 30, 2019
Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red EntitiesKristin K McNamara, John R Kalmar
Pageof 6